BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walia S, Chandrasekaran AR, Chakraborty B, Bhatia D. Aptamer-Programmed DNA Nanodevices for Advanced, Targeted Cancer Theranostics. ACS Appl Bio Mater 2021;4:5392-404. [PMID: 35006722 DOI: 10.1021/acsabm.1c00413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Askarian S, Nasab NK, Aghaee-Bakhtiari SH, Abadi MHJN, Oskuee RK. Investigating Efficacy of Three DNA-Aptamers in Targeted Plasmid Delivery to Human Prostate Cancer Cell Lines. Mol Biotechnol 2022. [PMID: 35834121 DOI: 10.1007/s12033-022-00528-7] [Reference Citation Analysis]
2 Qi S, Dong X, Sun Y, Zhang Y, Duan N, Wang Z. Split aptamer remodeling-initiated target-self-service 3D-DNA walker for ultrasensitive detection of 17β-estradiol. J Hazard Mater 2022;439:129590. [PMID: 35872451 DOI: 10.1016/j.jhazmat.2022.129590] [Reference Citation Analysis]
3 Tang T, Liu Y, Jiang Y. Recent Progress on Highly Selective and Sensitive Electrochemical Aptamer-based Sensors. Chem Res Chin Univ . [DOI: 10.1007/s40242-022-2084-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Chakraborty B, Das S, Gupta A, Xiong Y, T-V V, Kizer ME, Duan J, Chandrasekaran AR, Wang X. Aptamers for Viral Detection and Inhibition. ACS Infect Dis 2022;8:667-92. [PMID: 35220716 DOI: 10.1021/acsinfecdis.1c00546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jia H, Zhang Z, Fang X, Jiang M, Chen M, Chen S, Gu K, Luo Z, Wu F, Tan W. Recent advances of cell surface modification based on aptamers. Materials Today Nano 2022. [DOI: 10.1016/j.mtnano.2022.100188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Perumal D, Kalathil J, Krishna J, Raj G, Harikrishnan KS, Uthpala ML, Gupta R, Varghese R. Supramolecular grafting of stimuli-responsive, carrier-free, self-deliverable nanoparticles of camptothecin and antisense DNA for combination cancer therapy. New J Chem . [DOI: 10.1039/d2nj01952c] [Reference Citation Analysis]